BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10678972)

  • 1. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope.
    Cohavy O; Bruckner D; Gordon LK; Misra R; Wei B; Eggena ME; Targan SR; Braun J
    Infect Immun; 2000 Mar; 68(3):1542-8. PubMed ID: 10678972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of histone H1 as a cognate antigen of the ulcerative colitis-associated marker antibody pANCA.
    Eggena M; Cohavy O; Parseghian MH; Hamkalo BA; Clemens D; Targan SR; Gordon LK; Braun J
    J Autoimmun; 2000 Feb; 14(1):83-97. PubMed ID: 10648119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel mycobacterial histone H1 homologue (HupB) as an antigenic target of pANCA monoclonal antibody and serum immunoglobulin A from patients with Crohn's disease.
    Cohavy O; Harth G; Horwitz M; Eggena M; Landers C; Sutton C; Targan SR; Braun J
    Infect Immun; 1999 Dec; 67(12):6510-7. PubMed ID: 10569769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mimicry may contribute to pathogenesis of ulcerative colitis.
    Kovvali G; Das KM
    FEBS Lett; 2005 Apr; 579(11):2261-6. PubMed ID: 15848155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cell and neuroendocrine cytoplasmic autoantigen(s) detected by monoclonal pANCA antibodies.
    Gordon LK; Eggena M; Targan SR; Braun J
    Clin Immunol; 2000 Jan; 94(1):42-50. PubMed ID: 10607489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pANCA represents a cross-reactivity to enteric bacterial antigens.
    Seibold F; Brandwein S; Simpson S; Terhorst C; Elson CO
    J Clin Immunol; 1998 Mar; 18(2):153-60. PubMed ID: 9533659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in clinical laboratory tests for inflammatory bowel disease.
    Nakamura RM; Matsutani M; Barry M
    Clin Chim Acta; 2003 Sep; 335(1-2):9-20. PubMed ID: 12927679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning of a Bacteroides caccae TonB-linked outer membrane protein identified by an inflammatory bowel disease marker antibody.
    Wei B; Dalwadi H; Gordon LK; Landers C; Bruckner D; Targan SR; Braun J
    Infect Immun; 2001 Oct; 69(10):6044-54. PubMed ID: 11553542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis.
    Davis MK; Andres JM; Jolley CD; Novak DA; Haafiz AB; González-Peralta RP
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):409-13. PubMed ID: 18030205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural relatedness of enteric bacterial porins assessed with monoclonal antibodies to Salmonella typhimurium OmpD and OmpC.
    Singh SP; Upshaw Y; Abdullah T; Singh SR; Klebba PE
    J Bacteriol; 1992 Mar; 174(6):1965-73. PubMed ID: 1312535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients.
    Papp M; Altorjay I; Norman GL; Shums Z; Palatka K; Vitalis Z; Foldi I; Lakos G; Tumpek J; Udvardy ML; Harsfalvi J; Fischer S; Lakatos L; Kovacs A; Bene L; Molnar T; Tulassay Z; Miheller P; Veres G; Papp J; ; Lakatos PL
    Inflamm Bowel Dis; 2007 Aug; 13(8):984-92. PubMed ID: 17417801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological markers associated with disease behavior and response to anti-tumor necrosis factor therapy in ulcerative colitis.
    Kevans D; Waterman M; Milgrom R; Xu W; Van Assche G; Silverberg M
    J Gastroenterol Hepatol; 2015 Jan; 30(1):64-70. PubMed ID: 25041458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and significance of perinuclear anti-neutrophil antibodies (pANCA) in Romanian patients with Crohn's disease and ulcerative colitis.
    Preda CM; Vermeire S; Rutgeerts P; Joosens S; Diculescu M; Marica C; Ciocarlan M; Mirea V; Oproiu A
    Rom J Gastroenterol; 2005 Dec; 14(4):357-60. PubMed ID: 16400351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pANCA, ASCA, and OmpC antibodies in patients with ankylosing spondylitis without inflammatory bowel disease.
    de Vries M; van der Horst-Bruinsma I; van Hoogstraten I; van Bodegraven A; von Blomberg BM; Ratnawati H; Dijkmans B
    J Rheumatol; 2010 Nov; 37(11):2340-4. PubMed ID: 20810508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic testing of a panel of five antibodies in inflammatory bowel diseases: Diagnostic value and correlation with disease phenotype.
    Wang ZZ; Shi K; Peng J
    Biomed Rep; 2017 Apr; 6(4):401-410. PubMed ID: 28413638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of antibody responses against rectal mucosa-associated bacterial flora in patients with ulcerative colitis.
    Matsuda H; Fujiyama Y; Andoh A; Ushijima T; Kajinami T; Bamba T
    J Gastroenterol Hepatol; 2000 Jan; 15(1):61-8. PubMed ID: 10719749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil antibodies (pANCA) in chronic liver disease and inflammatory bowel disease: do they react with different antigens?
    Seibold F; Weber P; Schöning A; Mörk H; Goppel S; Scheurlen M
    Eur J Gastroenterol Hepatol; 1996 Nov; 8(11):1095-100. PubMed ID: 8944372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of serological markers to differentiate between ulcerative colitis and Crohn's disease: pANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods.
    Linskens RK; Mallant-Hent RC; Groothuismink ZM; Bakker-Jonges LE; van de Merwe JP; Hooijkaas H; von Blomberg BM; Meuwissen SG
    Eur J Gastroenterol Hepatol; 2002 Sep; 14(9):1013-8. PubMed ID: 12352222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease.
    Koutroubakis IE; Petinaki E; Mouzas IA; Vlachonikolis IG; Anagnostopoulou E; Castanas E; Maniatis AN; Kouroumalis EA
    Am J Gastroenterol; 2001 Feb; 96(2):449-54. PubMed ID: 11232689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.